EDESA BIOTECH, INC. Cash and Restricted Cash
EDESA BIOTECH, INC. (EDSA) had Cash and Restricted Cash of $10.33 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.33M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.00M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.05M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.79M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $10.33M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $10.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $12.05M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $10.79M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $12.36M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $13.90M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.56M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $1.04M 10-K · filed 2025-12-12 |
| 2024-06-30 | $2.04M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $4.27M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $5.36M 10-K · filed 2024-12-13 |
| 2023-06-30 | $6.46M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $7.47M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $8.27M 10-Q · filed 2024-02-09 |
| 2022-09-30 | $7.09M 10-Q · filed 2024-05-10 |
| 2022-06-30 | $12.81M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $15.89M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $5.88M 10-Q · filed 2023-02-10 |
| 2021-09-30 | $7.84M 10-K · filed 2023-12-15 |
| 2020-09-30 | $7.21M 10-K · filed 2022-12-16 |
| 2019-06-30 | $6.36M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $3.37M 10-Q · filed 2019-08-14 |
| 2018-06-30 | $3.94M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $5.00M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |